Dalacin-T Gel Post Approval Study

This study has been completed.
Sponsor:
Collaborators:
Parexel
SACT INTERNATIONAL Co., LTD.
Acronet
Bellsystem24 , Inc.
Mitsubishi Kagaku Bio-Clinical Laboratories, inc
Sato Pharmaceutical
Information provided by:
Pfizer
ClinicalTrials.gov Identifier:
NCT00219570
First received: September 13, 2005
Last updated: May 9, 2011
Last verified: May 2011
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: June 2005
  Estimated Primary Completion Date: No date given